Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis.
DSpace/Manakin Repository
Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis.
Beum, P.V.; Lindorfer, M.A.; Beurskens, F.; Stukenberg, P.T.; Lokhorst, H.M.; Pawluczkowycz, A.W.; Parren, P.W.H.I.; van de Winkel, J.G.J.; Taylor, R.P.
(2008) Journal of Immunology, volume 181, issue 1, pp. 822 - 832
(Article)
Download/Full Text
Open Access version via Utrecht University Repository
Unknown
ISSN: 0022-1767
Publisher: American Association of Immunologists
(Peer reviewed)
See
more statistics
about this item